Topical Gel

DRUG4 trials

Sponsors

GlaxoSmithKline, Universidad Católica de Ávila, University of Salamanca, Cutanea Life Sciences

Conditions

Humeral Epicondylitis, LateralPeriodontal DiseasePeriodontal InflammationSkin Irritationatopic dermatitis Eczema

Phase 2

A randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, safety, tolerability and efficacy of omiganan BID in patients with mild to moderate atopic dermatitis

Active, not recruitingNL-OMON42963

Cutanea Life Sciencesatopic dermatitis Eczema

Start: 2017-02-02Target: 80Updated: 2024-02-28

Phase 4

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

WithdrawnNCT02400320

GlaxoSmithKlineSkin Irritation

Start: 2016-03-01End: 2016-06-30Updated: 2017-09-12

Topical Metronidazole vs Control in Reducing Periodontal Pockets in a Split Mouth Clinical Trial

CompletedNCT06836401

University of SalamancaPeriodontal Disease, Periodontal Inflammation

Start: 2018-10-10End: 2022-11-10Updated: 2025-07-24

Unknown Phase

Effectiveness Of A Physiotherapy Treatment Plan In Lateral Epicondylalgia

CompletedNCT05021354

Universidad Católica de ÁvilaHumeral Epicondylitis, Lateral

Start: 2023-08-01End: 2023-10-30Updated: 2024-09-19

Related Papers

Efficacy of Dry Needling Combined with Eccentric Exercise Versus Oral and Topical NSAID Treatment in Patients with Tennis Elbow: A Randomized Controlled Trial

Journal of Evidence-Based Integrative Medicine2025-01-011 citations